The European Patent Office (EPO) has published patent application EP4629991A1, which concerns a delayed release composition designed to resist gastric conditions in a fed state. The publication date is March 18, 2026, and the applicant is Evonik Operations GmbH. This patent application relates to novel drug delivery systems.

This publication is primarily an informational notice regarding intellectual property. For companies operating in the pharmaceutical sector, particularly those involved in drug formulation and delivery, this patent publication may be of interest for competitive intelligence or potential licensing opportunities. No immediate compliance actions or deadlines are imposed by this patent publication itself.